Nathan D. Jorgensen, Chief Financial Officer at Voyager Therapeutics, Inc. (VYGR), sold 4,668 shares at $3.77 ($18K) on 2026-02-24, disclosed to the SEC on 2026-02-26.
Open-market sale of $18k VYGR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.